文献速递角膜与眼表疾病

角膜内皮移植术与角膜后弹力层剥除自动内皮移植术及穿透性角膜移植术的疗效比较

Descemet Membrane Endothelial Keratoplasty Versus Descemet Stripping Automated Endothelial Keratoplasty and Penetrating Keratoplasty.
PubMed 文献 · Am J Ophthalmol · 2019-06-19

这项回顾性比较队列研究基于新加坡角膜移植登记处的数据,比较了因FECD和BK接受DMEK(121眼)、DSAEK(423眼)或PK(405眼)患者的长期移植物存活与并发症。DMEK组总体累积移植物存活率最高(97.4%),排斥反应和术后眼压升高发生率最低。

要点

  • DMEK总体累积移植物存活率97.4%,高于DSAEK的78.4%和PK的54.6%(P<.001)。
  • FECD眼DMEK存活率98.7%,DSAEK为96.2%,PK为73.5%(P=.009)。
  • DMEK组移植物排斥率1.7%,低于DSAEK的5.0%和PK的14.1%(P<.001)。

核心结论

  • 因FECD和BK接受DMEK的患者,移植物存活优于DSAEK和PK;在相同适应证下,DMEK术后移植物排斥和眼压升高的发生率也显著低于DSAEK和PK。

研究设计与样本

  • 回顾性比较队列研究,纳入新加坡角膜移植登记处前瞻性队列中因FECD和BK接受DMEK(121眼)、DSAEK(423眼)或PK(405眼)的患者,采用Kaplan-Meier生存分析比较3组存活概率,主要结局指标为移植物存活。

主要发现

  • DMEK组总体累积移植物存活率97.4%,优于DSAEK的78.4%和PK的54.6%(P<.001)。
  • FECD眼中DMEK组移植物存活率98.7%,优于DSAEK的96.2%和PK的73.5%(P=.009)。
  • BK眼总体移植物存活较差,但DMEK组仍最佳,为94.7%,优于DSAEK的65.1%和PK的47.0%(P=.001)。
  • DMEK组移植物排斥率最低(1.7%),DSAEK为5.0%,PK为14.1%(P<.001)。
  • DMEK组术后眼压升高发生率最低(11.6%),DSAEK为23.6%,PK为22.5%(P=.015)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To compare the long-term graft survival outcomes and complications of patients who underwent Descemet membrane endothelial keratoplasty (DMEK), Descemet stripping automated endothelial keratoplasty (DSAEK), and penetrating keratoplasty (PK) for Fuchs endothelial corneal dystrophy (FECD) and bullous keratopathy (BK). DESIGN: Retrospective comparative cohort study. METHODS: Patients with FECD and BK who underwent DMEK (121 eyes), DSAEK (423 eyes), or PK (405 eyes) from the prospective cohort from the Singapore Corneal Transplant Registry were included. A Kaplan-Meier survival analysis was conducted to compare the survival probabilities of the 3 groups. The main outcome measure was graft survival. RESULTS: The DMEK group had the best overall cumulative graft survival of 97.4%, compared to DSAEK (78.4%) and PK (54.6%) (P < .001). In eyes with FECD, the DMEK group had the best graft survival of 98.7% compared to DSAEK (96.2%) and PK (73.5%) (P = .009). The graft survival in eyes with BK was poorer overall; however, the DMEK group still had the best graft survival of 94.7%, compared to DSAEK (65.1%) and PK (47.0%, P = .001). Eyes that underwent DMEK had the lowest rate of graft rejection (1.7% vs DSAEK 5.0% vs PK 14.1%, P < .001) and postoperative elevation of intraocular pressure (11.6% vs DSAEK 23.6% vs PK 22.5%, P = .015). CONCLUSIONS: Patients who underwent DMEK for FECD and BK had better graft survival compared to DSAEK and PK. Eyes that underwent DMEK also had a significantly lower rate of graft rejection and elevated intraocular pressure compared to DSAEK and PK for the same indications.

来源:Am J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Woo JH, Ang M, Htoon HM, et al. Descemet Membrane Endothelial Keratoplasty Versus Descemet Stripping Automated Endothelial Keratoplasty and Penetrating Keratoplasty. Am J Ophthalmol. 2019. PMID: 31228467. doi:10.1016/j.ajo.2019.06.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。